Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950005-04-000291
Filing Date
2004-03-24
Accepted
2004-03-24 17:00:51
Documents
2
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO ANNUAL REPORT p18314_10ka.txt 10-K/A 202101
3 CONSENT OF ERNST & YOUNG LLP p18314_ex23.txt EX-23.1 1003
  Complete submission text file 0000950005-04-000291.txt   204796
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-26372 | Film No.: 04687823
SIC: 2834 Pharmaceutical Preparations